Zhitong Finance App News, Siludi Pharmaceutical Co., Ltd. (01244.HK) announced that ionizable cationic lipids, a key component in lipid nanoparticles (LNP) independently developed by the company for nucleic acid drug delivery, have recently applied for a PCT patent.

Zhitongcaijing · 03/11 14:33
Zhitong Finance App News, Siludi Pharmaceutical Co., Ltd. (01244.HK) announced that ionizable cationic lipids, a key component in lipid nanoparticles (LNP) independently developed by the company for nucleic acid drug delivery, have recently applied for a PCT patent.